Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DBDW | ISIN: GB00BMD0WG01 | Ticker-Symbol: T61
Stuttgart
28.08.24
08:08 Uhr
0,002 Euro
0,000
0,00 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
CHALLENGERX PLC Chart 1 Jahr
5-Tage-Chart
CHALLENGERX PLC 5-Tage-Chart
PR Newswire
146 Leser
Artikel bewerten:
(0)

ChallengerX Plc - Potential Acquisitions Update

Finanznachrichten News

ChallengerX Plc - Potential Acquisitions Update

PR Newswire

LONDON, United Kingdom, January 20

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

20 January 2025

ChallengerX plc

("ChallengerX", "CXS" or the "Company")

Potential Acquisitions Update

ChallengerX (AQUIS: CXS) is pleased to share the following update regarding its progress on potential strategic transactions, as outlined in previous announcements dated 29 October 2024 and 8 January 2025. The Board is in active negotiations with the owners of Nyce International Limited ("NYCE") and Virya VC Limited ("Virya"), with the aim to acquire their entire issued share capital. In addition, as part of this transaction, ChallengerX intends to enter into a perpetual, irrevocable licensing agreement in relation to an instance of Reelsoft AB's Vision RGS (Remote Gaming Server) and Game Aggregation Platform (together, the "Potential Acquisitions").

The Company is at an advanced stage of its legal and financial due diligence process and negotiation of the share purchase agreements and licensing agreements. The consideration for the Potential Acquisitions is expected to be satisfied fully in the issue of new ordinary shares of £0.001 each ("Ordinary Shares").

The Board is also negotiating certain new board appointments and working alongside an Aquis Corporate Adviser to conduct a review of the potential candidates' experience and background as well as of the enlarged group's suitability, following completion of the Potential Acquisitions and readmission to trading on the Aquis Stock Exchange.

It is not expected that the Potential Acquisitions would constitute a Reverse Takeover under Rule 3.6 of the Access Rulebook.

The Potential Acquisitions are subject to a number of conditions, including the completion of due diligence to the satisfaction of all parties, the lifting of the suspension to trading of ChallengerX Shares by Aquis Stock Exchange, the issue and admission of the new Ordinary Shares to trading, and completion of a fundraise in a sufficient amount to satisfy the enlarged group's working capital requirement.

Information about NYCE

Nyce International Limited, a Hong Kong based company, represents a gaming marketplace of intelligent, success-driven technologies and services that deliver measurable revenue growth and operational efficiency to gaming companies. Via their global network, NYCE accelerates the sales and product distribution process for the companies they represent, facilitating conversations at only the highest levels. NYCE exhibits at all the major gaming conferences worldwide to showcase its comprehensive product portfolio that further drive revenue potential and brand trust.

Information about Virya

Virya, a UK based company, is a venture studio and investment firm that houses a multi-discipline advisory partner network with global access to deal flow within the betting and gaming industry. Virya provides executive and directorship services across all the key sub sectors of the industry being; product strategy, technology, AI, regulatory, licensing, compliance, affiliates marketing, payments and trading risk management.

Information about Vision RGS and Game Aggregation Platform

The purchase of an instance of Reelsoft AB's Remote Gaming Server ("RGS") and Game Aggregation Platform represents a strategic opportunity for CXS to synergetically integrate the portfolio of game content partners of NYCE and Virya in order to better promote and distribute to operators worldwide.

The completion of Potential Acquisitions and relisting of ChallengerX Shares on the Aquis Stock Exchange cannot be guaranteed.

The directors of ChallengerX accept responsibility for this announcement.

For further information, please contact:

ChallengerXplc

John May, Chairman

jmay@city-westminster.com

Stuart Adam, CFO

sjadam@city-westminster.com




© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.